Table 1, Selection Criteria - Fluoroquinolones for Intra-Abdominal Infections: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Population	Patients with intra-abdominal infections (e.g., secondary peritonitis, cholecystitis, ascending cholangitis)
Intervention	Fluoroquinolones
Comparator	Q1-Q2: Any antibiotic comparator Q3: No comparator
Outcomes	Q1: Clinical effectiveness; harms (e.g., Clostridioides difficile infections) Q2: Cost-effectiveness Q3: Guidelines
Study Designs	Health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, non-randomized studies, economic evaluations, guidelines

From: Fluoroquinolones for Intra-Abdominal Infections: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Cover of Fluoroquinolones for Intra-Abdominal Infections: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Fluoroquinolones for Intra-Abdominal Infections: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet].

Gray C, Loshak H.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Apr 25.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Table 1Selection Criteria